Molecular Glue Discovery: Current and Future Approaches

被引:42
|
作者
Dewey, Jeffrey A. [1 ]
Delalande, Cleïmence [2 ]
Azizi, Saara-Anne [3 ]
Lu, Vivian [2 ]
Antonopoulos, Dionysios [1 ]
Babnigg, Gyorgy [1 ]
机构
[1] Argonne Natl Lab, Biosci Div, Lemont, IL 60439 USA
[2] Univ Chicago, Dept Chem, Chicago, IL 60637 USA
[3] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA
关键词
PROTEIN-PROTEIN INTERACTIONS; E3 UBIQUITIN LIGASE; TOPOISOMERASE-II; STRUCTURAL BASIS; TRANSCRIPTION FACTOR; POSE PREDICTION; DRUG DISCOVERY; INHIBITORS; ACTIVATION; COMPLEX;
D O I
10.1021/acs.jmedchem.3c00449
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The intracellular interactions ofbiomolecules can bemaneuveredto redirect signaling, reprogram the cell cycle, or decrease infectivityusing only a few dozen atoms. Such "molecular glues,"which can drive both novel and known interactions between proteinpartners, represent an enticing therapeutic strategy. Here, we reviewthe methods and approaches that have led to the identification ofsmall-molecule molecular glues. We first classify current FDA-approvedmolecular glues to facilitate the selection of discovery methods.We then survey two broad discovery method strategies, where we highlightthe importance of factors such as experimental conditions, softwarepackages, and genetic tools for success. We hope that this curationof methodologies for directed discovery will inspire diverse researchefforts targeting a multitude of human diseases.
引用
收藏
页码:9278 / 9296
页数:19
相关论文
共 50 条
  • [1] Current and future approaches for in vitro hit discovery in diabetes mellitus
    Zhang, Xin
    Kupczyk, Erwin
    Schmitt-Kopplin, Philippe
    Mueller, Constanze
    DRUG DISCOVERY TODAY, 2022, 27 (10)
  • [2] Discovery of a molecular glue for EGFR degradation
    Wang, Hairui
    Wang, Hui
    Wang, Rui
    Li, Yuanzhen
    Wang, Zhipeng
    Zhou, Wenshen
    Deng, Li
    Li, Xiyin
    Zou, Li
    Yang, Qin
    Lai, Ren
    Qi, Xiaowei
    Nie, Jianyun
    Jiao, Baowei
    ONCOGENE, 2025, 44 (08) : 545 - 556
  • [3] Current and future molecular approaches in the diagnosis of cystic fibrosis
    Bergougnoux, Anne
    Taulan-Cadars, Magali
    Claustres, Mireille
    Raynal, Caroline
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2018, 12 (05) : 415 - 426
  • [4] Molecular modeling approaches for the discovery of adenosine A2B receptor antagonists: current status and future perspectives
    Deb, Pran Kishore
    Chandrasekaran, Balakumar
    Mailavaram, Raghuprasad
    Tekade, Rakesh Kumar
    Jaber, Abdul Muttaleb Yousef
    DRUG DISCOVERY TODAY, 2019, 24 (09) : 1854 - 1864
  • [5] Chasing molecular glue degraders: screening approaches
    Domostegui, Ana
    Nieto-Barrado, Luis
    Perez-Lopez, Carles
    Mayor-Ruiz, Cristina
    CHEMICAL SOCIETY REVIEWS, 2022, 51 (13) : 5498 - 5517
  • [6] Molecular Diagnostics for Invasive Fungal Diseases: Current and Future Approaches
    Pham, David
    Sivalingam, Varsha
    Tang, Helen M.
    Montgomery, James M.
    Chen, Sharon C. -A.
    Halliday, Catriona L.
    JOURNAL OF FUNGI, 2024, 10 (07)
  • [7] Computational approaches in chemogenomics and chemical biology: current and future impact on drug discovery
    Bajorath, Juergen
    EXPERT OPINION ON DRUG DISCOVERY, 2008, 3 (12) : 1371 - 1376
  • [8] Leveraging Structural and Computational Biology for Molecular Glue Discovery
    Kang, Congbao
    Xu, Weijun
    JOURNAL OF MEDICINAL CHEMISTRY, 2025, 68 (03) : 2048 - 2051
  • [9] Emerging strategies for prospective discovery of molecular glue degraders
    Wang, Baiyun
    Cao, Shiyun
    Zheng, Ning
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 2024, 86
  • [10] Molecular Pathogenesis of Neuroendocrine Tumors: Implications for Current and Future Therapeutic Approaches
    Oberg, Kjell
    Casanovas, Oriol
    Castano, Justo P.
    Chung, Daniel
    Delle Fave, Gianfranco
    Denefle, Patrice
    Harris, Philip
    Khan, Mohid S.
    Kulke, Matthew H.
    Scarpa, Aldo
    Tang, Laura H.
    Wiedenmann, Bertram
    CLINICAL CANCER RESEARCH, 2013, 19 (11) : 2842 - 2849